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One ofthe major health problems that
take attention fof most women. especiall)
$ ' ! r ' i  r )  o!er b0 )ear.  old.  is o ' teoporo' i '
because i ts increase in number and inciderree
of hip fracture. According to Mitchell and
Stancel (2001),  20% ot those who suffer hrp
fracture passed away l2 monlhs after thc
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Abstract
One ofthe maior health problems in elderly women is osteoporosis post menoplusc. Dentisrs must
be aware of the disease since its involvement on the jaw. Nowadays, there are a lol of researches on
correlation ofosteoporosis and mandible but onl-v felr concenlrate on hormonal substitution therapy and/or
Calcium-vitamin D3 (Ca-vit Dr). This research is to evaluate the effect of hormonal substitution therapy
and/or Ca-vit D3 on mandibular height. Forty five rars arc used in ihis research and divided into nine Sroupi
one control grcup. two ovariecbmized (OvX) groups. t\vo OVX groups treated with edrogen. lwo OVX
srorips lreated wilh Ca-vit Dr two OVX groups tfeated \vith csfiogen and Ca'vit I)r All oflhe rals except
th€ control grcups $ere ovariectomized as model tbr postmenopausal estrogen deficienc) statc The
rreatment wrs done in two or four weeks. The animals were killed with cervical dislocation. lhe mandiblc
were cxcised and soaked on Hydrogen Peroxide l0o.,o lhen the mandible s heights on righl buccal sjde
were measured tionr the mandibular base !o the alveolar crest. li is concluded thar hormonal substitulion
therapy and combination of thc hormonal substilution therapy aDd Ca-vit Dl can mainmin the nonnal
nrandibular height. Mandibular height ol groups with therapy using Ca-vil D, have slightly lowet mcans
compared to conirol group but withoul signilicanl difference slalistically. The best therap) is combrnahon
ofhormonal  subni tu l ion thcrap)  and Ca-v i t  Di .
Key words: Menopause. osteoporosis. ovariectom). Estrogen. Calciunr. Vlramin D., and Mandibulal
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lntroduction.
incidence.r The increase of bone resorption-
'which exceeds norrnal resorption rate $itholrt
bone apposit ion, is common in eslrogcn
def ic iency state. lh is cause bone loss and
decreasc of bone den.rr1.:  \ \  i t l r  aging. i t  i r
found that there is a decrease oD corlical
nandibrr lar ma.s. bLr nul or)  t rabccular pan.
Evcn though, still there are controversial
Henn t). f.t||ih ./i,,,* G Nitilarq, ZD , Dev t f, 4]]sh S
ar!:uments on the relationshrp betlreen
nral ldible and o&ef parls of bodl. '
I  h .  r <  l , , t i " n . h i p  c n  d e r r t i . r r  r  .  q r r i t e
. lerr  rrrz, t  I '<ropaL,.al  $orrren ohen c^mpldirr
s i r h  h e r  d e n r . f c .  I  r . e . . i r e  i a $  r c , n r p t i c n
\\ i i l  cause instabi l i ly of the denture. Implants
dre cojrr f i l | l lL l iLar i \ r  bc.dusc i , r$ . , rn nor gi \e
support  fbr implants."  OsteopeDia happens on
periodontal tissues that- can cause teeth
rnobi l i ty and avLrls ion. '  '  Even unt i l  today.
there are a lo1 of rcscarcbes on correlation of
J.reotcr,s i \  and man.l ib le but onh t( \ !
eonccntratc on honnonal substitution therap]
. l | rdr)r  Ca-vi l  D. on rrandible. Research lhr l
. i l l  shovr the eff 'ect of  hornronal subst i tutrrr
rherapv and/d Cit  \  i t  Dr on bonc rs
o!ar icctomy on rats Bi lateral  ovariectomized
rnts acl  as nrodels to perlbrm menopausal
\tale.i I his rcscarlh uscs ovaricclorrizcd
\\'istar rats aDd evaluales lhe effecl of
r \af iecloni]  and honno|al  subst i tui ion
rherap_!.m and/or Ca-vi t  Dr on rnandibulal
) laaerials and Methods
Forty-five. four months old. female
\\  istar rats.  rvcighing bct$,clrn 154'258 g
L ,r  l . : , \c di ! (  hinh J,  lea.r  ^ nce $ere u.ed ' r l
:h s rescarch. ' l 'hcy \ \crc dividcd cqLral lJ-u inro
,nc conlfol  group and eight experimeDtal
Jroups wi lh rwo ovariectomy groups (OVX).
r$o OVX groups trcated with estrogcn ( l -S'  , .
r$o OVX groups lreared wi lh Ca-vi t  Dr(Ct,
r{ . '  OVX groups trcatcd wi lh estrogen and
. . \  r  f )  r l {  D ) .  I  I J < r  g c n e f d l  a r e . l l r e . r a
s r ih dieth) l  eter.  the micc under\ ,enl
ovaricctonrJ except he contfol  group. In each
of the e\perincntal  groups, the mice $efe
killcd trro and four r,'eeks after operalion
I-lslrogeD preparations (cstradiol hemihydrates
2 mg tablets:  ESTROIiLM. NOVO
NORDISK) and Ca-vi t  Dr preparat ions (C-a
hydrogen phosphate dihldrate 500 mg and
133 IU cholecalci ferol  tablets:  CAVIT-Dr.
MLRCK) werc dissolvcd in 10% Carbory
Mcthyl Cellulose and given per oral daily.
The mice were ki l led b] ccrr ical
dislocat ion and their  mandibles \efe remo\ed
ancl soaked in l0% UrOr solut ion lbr:  da,,"
Aficr thc bones $ere liec tiom the soli
t issucs. the nrandibular l lc igl l l  $as rrcasured
l ionl  thc alveolar crest on buccal of  the f i fst
\4olaf to infer ior edge of the mandible usrng
dig{al  cal ipers.
Onc Way ANOVA \r'ere used to tesl
for the diffe.cncc bet$ccn thc groups: P
valucs ol  less than 0.05 $crc considered
stat ist ical l )  s igni f icanl.
Rcsults
I  i g  I  a n d  I  i g .  )  . h o u  c l r a n y e r  r r
nrandibular height of  the control  and
lreatment groups. 'Ihe mandibular hcights of
al l  nvo weeks group's show no s'gDi l jcanl
drf ference with thc control  groups. ] 'hc OVX.
ESf. and ECD groups show sl ight deorease
compared to conrrol  group. During lour
\\'eeks observation fime, signifi cant diflcrcncc
was shown by ECD aDd control  group. Onl]
OVX and CD groups sholv lower vnlues (]1
mandible height.
- : -  r  T l m i a h  K P P I K G : l t
The Etfed Ol Esrase" ,lnrl ot
Height OJ Post (,\drietkrni:d






Fig. L V aDdibular hcrghr on 1\! o wccks obscrvafion







Osteoporosis is one ol majoL probienr
faced b1 po.tmenopaL,-al  rromer hecru.e r t-
high r isk of bonr f i . rcrrrre..  Uslrufuru\r .
happens when thefe is imbalance between the
rate of bone formalion and rcsoryuon.
Postmenopausal estrogen deflciency state
gives direct in fluences on dcntal treatmenl.
The quality and quarlily of ahcolar bonc
should be considered in dcsigning dentures.
Specimens used in this research Are wrstar
rals that had given birlh !o casc olaricclomJ,
procedure. Mandibular height uas measured
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on the buccal s ide of thef i rst  mol on lwo
and lbur $,ccks after operation. Ka\\'amotL)
(2u02) obscr!cd lhat 'l1L4.P positivc cclls are
abundantly found on bucca I side ol mcsial
root of filsl nolar and cstrogcn dcficienc)
state increases osteoclast fomlation $ilhin l:1
days cvcn lhough pre-osteoclast activiry had
b<gurr -  d:r1. dlrer o\af i (c lom) H r.r
(1991) states a significant difference betrvccn
thc hcight ofihc mandible with the severity of
osteoporosis and no specific chargcs on
blood (.r  rnd P lc\cl  ol  o-reopofur ir
*TRAP ( Tanraie Rcsistanl Acid Phosphalasc )
is a specific marker for ostcoclast
Icmu l lmiah KPPIKC XI I I
\ \orncn. laguchi (1995) states that besides
l lone Density Measurement (BlVfD). alveolar
bonc height is a rel iable measure on
diagnosirg osteoporosis. '
The present result indicates that
InandibLrlar heighr \ !as not charge for al l
groups during two \!eeks after o\'ariectomy.
Bod) can st i l l  maintain Ca honteostasis even
lhough cstrogen lcvcl has decreased. Blood
cstr):{en lcvel \i'as not completely reduccd
.rI \ r  o\nnecro'n).  bul  lhe decfea<c i l l
estk)gen lcvcl  $i i l  be compensated. ln
postrnenopausal wolnen, blood estrogen level
. I . . , "ut"  u.  rruch 12 pg /  24 hours. '
Lstradiol  erel  in ovariectomized rat \as 6 5
pmol ,  l i ler and in nornral  rat  as nruch l l  5
pmol ,' liter '' 'l'hl]re are anothet source oi
estrogen other than ovaries $hich is the
adfenal concx. Besides that growth honnone.
'n,1. rr .  , tnd lhlrord rr< al .o haring role i rr
pfe\ent ing f 'ast bone loss. ' '  ln corclusion.
jhorl-tel'ln estrogen deficiency sta{e is not the
orl \  l ic lor lhat cause bone loss.
During, l  * ,eeks period, the decrease
in nrandibular heighl can be observed. The
elf((r ,  t  e ' l roperr def ic ier)c) i r  the increa.e i ' l
onec. last fonnat ion in 1,1 days. "  Fuj i ta states
rha! the increase of TRAP posit ive cel ls and
decrcase in bone trabecular volurre of
o\arieclonrizcd wistar rats were found four
*ccks after o!ar icctomv. r '  This research
irNlcs rhat there is a decrcasc in mandibulaf
heighl of  thc OVX '1 group conpafed to
Blank even though i t  is not s igni f icaDt
irat ist ical ly.  I f  the sample nurrber increased
or observaiion time lengthencd, the ditlereDce
$oukl bc rnore signi f icant
Hof lnonal ReplacemeDt Themp)
{HRT) is a chosen therapy for el i ln inat ing the
estrogen def ic ienc) state.r  r1 rB l- ippen states
rhat estradiol prepafation can be used as frrst
ihoice for HRT in post menopausal women. i
E5lradiol is thc most effective preparation for
huqrrn and the nrost s imi lar preparat ion to
hod) 's natural  .honnone. The side effect of
ertradrol  is l iDr i lcd bccause i t  or ly induces
i-c\\ hean proteins. ' Even though, still there
arc increase of the r isk of stroke, venous
' ' ' r '  r rr l .u cmhol. .  p.rr .rcdl i l i \ .  errdornetnu>i. .
l l l rd !agina. breast,  endometr i rm. ovan
aa|cer.  '  The conbinat ion of esirogen and
lrogesrerone reduces lhe r isk of those side
ienrr l lnr iah KPPIKG
Estrogen inhibits bone resirPc
process through its effect o[ osteoblag and
osreoclast. lt is known that osteoblast and
osteoclast have estrogei receptors. Estrogen
sti,nulates dilTerentiatioD of osteoblast
throueh osteocalcin. osteoDontin, osteonecltr.
a I d  a l k a l i n e  p h o c p h a t a s e '  I n r e r l e u l i | l - 1 . 6 . 1  l :
Transforming
Macrophages-Colony St imulat ing l iactor,
le kocyte inhibiting factor. arrd ste|n cell
factor are signals form osteoblast $hich
act ivate osteoclast.r i  Estrogen can inhibi t
osteoclast act ivat ion through inhibi t ion of
thosc cytokines and increasirg m-RNA
expression for Insul in- l ike Growth Factor- l
and TGF-F. "  Estrogen can also gl lc di fect
effcct on osteoclast with acceleration ot
osteoclast apoptosis.' This research proves
that on EST 2 and EST,l  groups show no
significant difference compared to conlrol
group. ln conclusioD. adnrinistral ion of
estradiol as hornroDe replacemcnt therapy rs
effect ive to maintain nrandibular height.
The rnain role of v i tamin D is t l te
regulat ion of catcium homeostasis o thal
litamin D. has various receptors on various
organs, especially in the intcstine arrd bone.
Vitamin Dr plays a role on increasing calcium
db5orpl ion i r  the inre(t ine. On bone. \ i lamin
Dr reduces bone rerrodel ing pfocess and
irrcred'e. bo| le nrd..  lhrough rrrcrea' i rr !
osteocalcin level $hich increase bone mass
and density through osteoblast recruinnenl ''
Cornbinat ion of v i tamin Dr and Ca is ver)
usef l l  for pos!menopausal \ ' !omen. Calciunr
intake as much 1500 mgday added with
vi ta in Dr as much ,100 IU is a suggesled
dose for post nenopause women,l
Combinat ion of v i tamin Dr and Ca can
decrease serum Parathyroid Hormone (PTH)
level." The decrease of serum PTH level
decreases bone resofption activity. so lhal
there is a reduce of boDe loss on post
Inenopausal women. I fserunr calcium level is
high, v i tamin Dr wi l l  Duch grealer
hydroxylated iDto 2,1. 25 (OH)r Di
(secalci ferol)  rvhich sr imulatcs bone
formation.t"  on rhe othef hand, high
corcentrat ion of calcium-vi tamin Dl can
st inulaic bonc resorpt ion.through iDhibi l ron
o l  b o n e  c o l l a g e r  - ) n l h e < i s . '  C l r l c i u n r - ! i t a m i r l
D  r l r e f n p )  a .  . i r ) c l (  r h ( r , r p )  i '  q u i t e  e t l i c l i \ (
on Inaintaining Irrandibular height Even
cro\\'1h Factor-0.
Tht Elllcl l)l l:stt1)'tt, !t1l t)t Ctlrtt"l I i!rntn Dl t)h Tht l\luhLlll,tldr
l!ulh1 ()l Pa\! O\\u itttoktl:cJ ll istdt Rdt\
though. cstrogen s role is qui te signi f lcant orr
calcium metabol ism. Estrogen adninistrat ion
(nh.rn.e\ lhc . ,11\ ium ab.orpl ion ralc in
intest ine and calcium retent ion i r  k idnel ' . '
l -he presenl stud) gives simi lar result  that
therc is no significant difterence of CD 2
gfoup compared to control group.
CornbiDation benreen estrogen.
calcium. and \ i tamin Dr is a Btore effect ive
therapy Io prevent excessive bone resorption.
Loose-Mitchel l  states thai  enough calciunr
ard vi tanr in Dr intake on dai ly foods can
increase the succcss of HRT. '  Combinal ion
rhelapy gives higher rate ofsuccess compared
lu . i r )gle rrr fdp) be.du.e uf i l .  s lncrg,- l ic
effact. Longer period of therapy ma)
eventual l )  increase mandibular height.  The
sini lar result  reported by Ci\ i le l l i  (2001)
\ . 'h ich state there is an increase of al \eolar
bone hcight al ier esfogcn. calcium. and
vitarnin Di administrat ion fof  three )cars on
p u i r  n r e r r . n n u . a l  $ o n l c l l  l l r  i o n a l J ( , o l l .
combinal ion thcrap) in long pcr iod is the
nost ef iect ive therapy on maintaining thc
nun. l ibular height.
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